Robert Chen, Paul B. Fitzgerald and Daniel M. Blumberger
Transcranial magnetic stimulation (TMS) is a widely used non-invasive brain stimulation technique. It represents an exciting new frontier in neuroscience research and can be used to examine neural processes, providing insights into pathophysiology and treating a variety of neuropsychiatric
illnesses.
A Practical Guide to Transcranial Magnetic Stimulation Neurophysiology and Treatment Studies presents an overview of the use of TMS as both an investigational tool and as treatment for neurological and psychiatric disorders. The chapters include an overview of the history and
basic principles of TMS and repetitive TMS (rTMS), the different types of TMS coils, different stimulation approaches, the use of neuronavigation, and safety considerations. The utility of single and paired TMS techniques to measure cortical inhibition, facilitation, connectivity and reactivity in
motor and non-motor brain areas, the different methods of using TMS to induce brain plasticity, and use of TMS in cognitive studies are explored. It also covers TMS and rTMS combined with electroencephalography (EEG) in neurophysiological studies. The authors provide a summary of the clinical
applications of TMS in neurological and psychiatric disorders including depression, schizophrenia, stroke, Parkinson disease, and pain.
This up-to-date volume provides a compendious review of the use of TMS and rTMS that will help guide the utility of this methodology in both clinical
and research settings. This practical guide will be a useful resource for those new to the field, as well as experienced users, for both research and clinical settings.
Preface
Acknowledgement
Section 1: TMS neurophysiology
1. History of TMS and basic principles of TMS and rTMS
2. TMS and neuronavigation equipment
3. Single, paired, triple pulse TMS for motor physiological studies
4. Induction of motor cortical
plasticity with TMS
5. TMS in non-motor neurophysiological studies
6. TMS in cognitive studies
7. TMS with EEG
8. Combining TMS with neuroimaging
Section 2: rTMS as treatment of neurological and psychiatric disorders
9. The use of rTMS and other forms of brain
stimulation in the treatment of neuropsychiatric disorders
10. Clinical applications of TMS in stroke
11. rTMS as treatment for movement disorders
12. rTMS as treatment for other neurological disorders
13. rTMS for the treatment of depression
14. rTMS for other psychiatric
disorders
15. Safety considerations and management of TMS side effects
There are no Instructor/Student Resources available at this time.
Dr. Robert Chen is currently a Professor of Medicine (Neurology) at the University of Toronto, the Catherine Manson Chair in Movement Disorders, Senior Scientist at the Krembil Brain Institute, and Editor-in-Chief of the Canadian Journal of Neurological Sciences. He received his MA and medical
degrees (MBBChir) from the University of Cambridge and an M.Sc. from the University of Toronto. He undertook a Neurology residency at the Western University and fellowship at the National Institute of Neurological Disorders and Stroke. His research interests are human motor physiology, brain
plasticity and understanding the pathophysiology and the development of new treatments for movement disorders such as Parkinson's disease and dystonia.
Dr. Daniel M. Blumberger is the Temerty Chair in Therapeutic Brain Intervention at the Centre for Addiction and Mental Health and a
Professor in the Department of Psychiatry at the University of Toronto. He received his MD from the University of Toronto where he also completed psychiatry residency and a fellowship in neurostimulation and geriatric psychiatry. He is involved in training and mentoring on the clinical delivery
neurostimulation treatments. His research broadly spans the use of neurostimulation therapies for refractory psychiatric disorders with a focus on clinical intervention trials and understanding the neurophysiology of treatment resistant depression across the lifespan.
Paul Fitzgerald
is Professor of Psychiatry at Monash University and Director of the Epworth Centre for Innovation in Mental Health. He is a qualified psychiatrist, with an MBBS degree, Masters of Psychological Medicine, and research PhD from Monash University. He has conducted an extensive range clinical trials of
novel brain stimulation and pharmacological interventions to improve treatment options for patients with depression, schizophrenia, obsessive compulsive disorder, PTSD, autism and Alzheimer's disease along with many experimental studies. He has established multiple clinical TMS services and founded
several device and clinical service companies, as well as the first TMS training program in the southern hemisphere.
